DERM

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.26
Percentage change -4.78	%

Peers: EBS PTCT ANAB RVNC IRWD CAPR CDTX AVDL ATNM MNOV

| Held by: VTI VXF IWC DFAC DFSU DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	51.16%	Shs Outstand	14.73M	Perf Week	-7.33%
Market Cap	108.21M	Forward P/E	-	EPS next Y	-0.28	Insider Trans	-0.12%	Shs Float	10.20M	Perf Month	-7.17%
Income	-18.34M	PEG	-	EPS next Q	-0.20	Inst Own	17.68%	Short Float	0.75%	Perf Quarter	3.39%
Sales	57.77M	P/S	1.87	EPS this Y	-376.19%	Inst Trans	102.23%	Short Ratio	0.72	Perf Half Y	-12.79%
Book/sh	0.53	P/B	9.83	EPS next Y	71.80%	ROA	-28.22%	Short Interest	0.08M	Perf Year	-14.80%
Cash/sh	1.08	P/C	4.82	EPS next 5Y	-	ROE	-129.58%	52W Range	2.85 - 8.11	Perf YTD	-10.07%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-59.70%	52W High	-36.13%	Beta	0.90
Dividend TTM	-	Quick Ratio	1.03	Sales past 5Y	23.37%	Gross Margin	57.32%	52W Low	81.75%	ATR (14)	0.38
Dividend Ex-Date	-	Current Ratio	1.38	EPS Y/Y TTM	-27.91%	Oper. Margin	-31.18%	RSI (14)	43.52	Volatility	6.16% 6.90%
Employees	58	Debt/Eq	1.93	Sales Y/Y TTM	-27.69%	Profit Margin	-31.74%	Recom	1.00	Target Price	9.80
Option/Short	No / Yes	LT Debt/Eq	1.81	EPS Q/Q	-114.58%	Payout	-	Rel Volume	0.83	Prev Close	5.44
Sales Surprise	1.66%	EPS Surprise	29.41%	Sales Q/Q	-57.64%	Earnings	Nov 12 AMC	Avg Volume	106.24K	Price	5.18
SMA20	-3.92%	SMA50	-8.96%	SMA200	8.06%	Trades		Volume	87,988	Change	-4.78%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-22-24	Initiated	Rodman & Renshaw	Buy	$9
Jun-28-24	Resumed	ROTH MKM	Buy	$11
Dec-07-21	Initiated	B. Riley Securities	Buy	$14

Nov-14-24 04:10PM	Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-12-24 05:25PM	Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.06%
04:01PM	Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-05-24 11:29AM	FDA approves Journey Medicals rosacea treatment Emrosi (Pharmaceutical Technology)
Nov-04-24 07:18AM	Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? (Zacks) -13.78%
07:00AM	Loading…
07:00AM	Journey Medical Corporation Announces U.S. FDA Approval of Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea (GlobeNewswire)
Oct-25-24 08:30AM	Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference (GlobeNewswire) +6.27%
Oct-17-24 04:15PM	SWK Holdings Provides Portfolio Update (ACCESSWIRE)
Oct-03-24 08:30AM	Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference (GlobeNewswire)
Sep-09-24 08:30AM	Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference (GlobeNewswire)
Sep-04-24 08:15AM	Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-13-24 04:05PM	Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire) +14.22%
Aug-12-24 05:10PM	Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -15.26%
04:01PM	Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-06-24 04:01PM	Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024 (GlobeNewswire)
04:15PM	Loading…
Jul-17-24 04:15PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (ACCESSWIRE)
Jul-11-24 04:05PM	Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors (GlobeNewswire)
May-15-24 04:15PM	Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
04:01PM	Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase (GlobeNewswire)
May-14-24 03:07AM	Journey Medical Corp (DERM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Growth ... (GuruFocus.com)
May-13-24 08:55PM	DERM Stock Earnings: Journey Medical Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:01PM	Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-07-24 08:30AM	Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
May-01-24 04:01PM	Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 08:30AM	Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 (GlobeNewswire)
Mar-28-24 04:05PM	Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) -5.40% -10.05%
Mar-25-24 07:01PM	Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM) (GuruFocus.com) -11.52% +26.37%
Mar-22-24 06:01AM	Q4 2023 Journey Medical Corp Earnings Call (Thomson Reuters StreetEvents) -13.61%
Mar-21-24 09:53PM	DERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:01PM	Loading…
04:01PM	Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-19-24 08:49AM	Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA (Zacks)
Mar-18-24 08:30AM	Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea (GlobeNewswire) +10.00%
Mar-15-24 08:30AM	Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024 (GlobeNewswire)
Mar-13-24 08:30AM	Journey Medical Corporation to Participate in the 36th Annual ROTH Conference (GlobeNewswire)
Mar-11-24 08:30AM	Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting (GlobeNewswire)
Feb-26-24 11:35AM	Journey Medical (DERM) to Report Q4 Earnings: What's in the Cards? (Zacks)
Jan-05-24 08:30AM	Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea (GlobeNewswire)
Jan-02-24 04:05PM	Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million (GlobeNewswire) -5.73% -8.29%
Dec-27-23 08:50AM	Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price Strength (Zacks)
Dec-13-23 08:09AM	Is it a Good Idea to Buy Journey Medical (DERM) Stock Now? (Zacks)
Dec-07-23 09:16AM	Journey Medical (DERM) Up on Update for Skin Disease Candidate (Zacks) +9.69%
Dec-06-23 08:00AM	Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea (GlobeNewswire) +6.10%
Nov-30-23 12:00PM	Are You Looking for a Top Momentum Pick? Why Journey Medical Corporation (DERM) is a Great Choice (Zacks) +5.43%
Nov-29-23 08:50AM	What Makes Journey Medical Corporation (DERM) a Good Fit for 'Trend Investing' (Zacks) -25.00%
Nov-14-23 04:10PM	Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-12-23 09:36AM	Journey Medical Corporation (NASDAQ:DERM) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 04:01PM	Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) +5.54% +9.62%
Nov-01-23 08:00AM	Jasper Therapeutics Announces Appointment of Thomas G. Wiggans as Chairperson of the Board of Directors (GlobeNewswire)
Oct-31-23 08:30AM	Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire) +5.94%
Oct-20-23 08:30AM	Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn (Minocycline Hydrochloride Extended-Release Tablets, 105 mg) (GlobeNewswire) +8.33%
Sep-09-23 01:04AM	Insider Buying: Journey Medical Corp's President & CEO Claude Maraoui Acquires 26,044 Shares (GuruFocus.com)
Sep-07-23 11:45AM	Journey Medical (DERM) & Maruho Ink Deal for Qbrexza Asia Rights (Zacks)
Sep-06-23 08:00AM	Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations (GlobeNewswire) +18.66%
Aug-14-23 04:01PM	Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-08-23 06:05PM	Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +12.15%
04:01PM	Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-03-23 05:35PM	Assertio (ASRT) Q2 Earnings Miss Estimates (Zacks) +7.14%
Aug-02-23 04:01PM	Journey Medical Corporation to Announce Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire)
Jul-19-23 08:30AM	Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023 (GlobeNewswire)
Jul-11-23 08:30AM	Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults (GlobeNewswire) -16.90%
Jul-04-23 07:34AM	Journey Medical (DERM) to Post Skin Disease Data, Stock Rises 26% (Zacks)
Jul-03-23 08:00AM	Journey Medical Corporation Expects Topline Results from the Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the Treatment of Papulopustular Rosacea to be Announced Week of July 10, 2023 (GlobeNewswire) +25.79%
Jun-14-23 12:03PM	Journey Medical (DERM) Up on Rosacea Candidate's Positive Data (Zacks)
Jun-13-23 12:11PM	Why Are Journey Medical Shares Trading Higher Today (Benzinga) +22.16%
08:30AM	Journey Medical Corporation Announces Positive Topline Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adult Subjects (GlobeNewswire)
May-22-23 05:15PM	Journey Medical Corporation (DERM) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -12.68%
04:01PM	Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-19-23 04:01PM	Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023 (GlobeNewswire) +33.33%
May-15-23 04:01PM	Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) -9.38%
May-11-23 04:01PM	Journey Medical Corporation Announces Postponement of First Quarter Financial Results Release and Conference Call (GlobeNewswire)
May-04-23 09:00AM	Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 11, 2023 (GlobeNewswire) +7.64%
Apr-19-23 02:22PM	Journey Medical Corporation (NASDAQ:DERM) Looks Inexpensive But Perhaps Not Attractive Enough (Simply Wall St.)
Apr-01-23 09:41PM	Journey Medical Corporation (NASDAQ:DERM) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-30-23 04:10PM	Fortress Biotech Reports Record 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire) +10.34% +11.17%
Mar-29-23 05:15PM	Journey Medical Corporation (DERM) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -6.57%
04:01PM	Journey Medical Corporation Reports Full-Year 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-28-23 05:35PM	Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +5.38%
Mar-22-23 09:00AM	Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023 (GlobeNewswire)
Mar-16-23 08:30AM	Journey Medical Corporation Announces Completion of Treatment Assessing Impact of DFD-29 (Minocycline Modified Release Capsules 40 mg) on Microbial Flora in a Separate Phase 1 Clinical Trial (GlobeNewswire)
Mar-07-23 08:30AM	Journey Medical Corporation to Participate in the 35th Annual ROTH Conference (GlobeNewswire)
Jan-20-23 04:01PM	Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer (GlobeNewswire) -7.57% +6.03%
Jan-10-23 08:30AM	Journey Medical Corporation Completes Enrollment in Phase 3 Clinical Trials Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Papulopustular Rosacea (GlobeNewswire) +15.62%
Dec-20-22 10:02AM	Journey Medical Touts Positive PK Data For Bacterial Infection Candidate (Benzinga) -8.46%
08:30AM	Journey Medical Corporation Announces Positive Comparative Pharmacokinetic (PK) Data for DFD-29 (GlobeNewswire)
Dec-05-22 04:05PM	Journey Medical Corporation to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference (GlobeNewswire) -7.57%
Nov-13-22 07:38AM	Journey Medical Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-10-22 05:25PM	Journey Medical Corporation (DERM) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -5.41%
04:01PM	Journey Medical Corporation Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-03-22 08:52AM	Journey Medical Corporation to Announce Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Oct-04-22 08:30AM	Journey Medical Corporation to Participate in Upcoming October 2022 Investor Conferences (GlobeNewswire)
Aug-30-22 08:30AM	Journey Medical Corporation Announces 50% Enrollment Milestone Achieved in Phase 3 Clinical Trials Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Papulopustular Rosacea (GlobeNewswire)
Aug-12-22 06:14AM	Analysts Have Lowered Expectations For Journey Medical Corporation (NASDAQ:DERM) After Its Latest Results (Simply Wall St.)
Aug-09-22 05:55PM	Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-04-22 10:00AM	Molecular Templates Inc. (MTEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Aug-03-22 08:00AM	Journey Medical Corporation to Announce Second Quarter 2022 Financial Results on August 9, 2022 (GlobeNewswire)
Jul-18-22 07:05AM	Entera Bio Announces Execution of Key Regulatory Milestones for EB613, the First Oral Anabolic Drug Proposed for the Treatment of Osteoporosis; Miranda Toledano Assumes CEO Position (GlobeNewswire)
May-24-22 08:30AM	Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity (GlobeNewswire)
May-23-22 08:30AM	Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference (GlobeNewswire) -10.67%

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Benesch Joseph	CFO	Aug 01 '24	Sale	5.47	9,324	51,002	47,331	Aug 01 04:18 PM
Benesch Joseph	CFO	Jul 23 '24	Sale	5.40	4,055	21,897	56,655	Jul 23 04:01 PM
ROSENWALD LINDSAY A MD	Director	Mar 25 '24	Buy	3.04	10,000	30,400	144,245	Mar 27 07:00 AM
Maraoui Claude	President & CEO	Mar 22 '24	Buy	3.48	10,000	34,790	2,163,430	Mar 25 04:03 PM
Smith Justin Adam	Director	Mar 22 '24	Buy	3.47	30,000	104,100	134,717	Mar 25 04:02 PM
ROSENWALD LINDSAY A MD	Director	Mar 22 '24	Buy	3.40	20,000	68,000	134,245	Mar 25 04:01 PM
Benesch Joseph	Interim CFO	Feb 22 '24	Sale	3.75	2,450	9,188	60,710	Feb 23 05:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Journey Medical Corp

Upgrade your FINVIZ experience